GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NIOX Group PLC (LSE:NIOX) » Definitions » EPS without NRI

NIOX Group (LSE:NIOX) EPS without NRI : £0.03 (TTM As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is NIOX Group EPS without NRI?

NIOX Group's earnings per share without non-recurring items for the six months ended in Jun. 2024 was £0.01. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Jun. 2024 was £0.03.

During the past 12 months, NIOX Group's average earnings per share (NRI) Growth Rate was 38.90% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 0.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for NIOX Group's EPS without NRI or its related term are showing as below:

During the past 13 years, NIOX Group's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 32.00% per year. The lowest was -60.30% per year. And the median was -35.50% per year.

LSE:NIOX's 3-Year EPS without NRI Growth Rate is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 9
* Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.

NIOX Group's EPS (Diluted) for the six months ended in Jun. 2024 was £0.01. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Jun. 2024 was £0.03.

NIOX Group's EPS (Basic) for the six months ended in Jun. 2024 was £0.01. Its EPS (Basic) for the trailing twelve months (TTM) ended in Jun. 2024 was £0.03.


NIOX Group EPS without NRI Historical Data

The historical data trend for NIOX Group's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NIOX Group EPS without NRI Chart

NIOX Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.04 -0.07 0.01 0.03 0.02

NIOX Group Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.02 0.01 0.01 0.02 0.01

Competitive Comparison of NIOX Group's EPS without NRI

For the Medical Devices subindustry, NIOX Group's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NIOX Group's PE Ratio without NRI Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NIOX Group's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where NIOX Group's PE Ratio without NRI falls into.



NIOX Group EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NIOX Group  (LSE:NIOX) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


NIOX Group EPS without NRI Related Terms

Thank you for viewing the detailed overview of NIOX Group's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


NIOX Group Business Description

Traded in Other Exchanges
Address
Edmund Halley Road, Hayakawa Building, The Oxford Science Park, Oxford, GBR, OX4 4GB
NIOX Group PLC is a medical device company that develops a range of therapies for asthma, chronic obstructive pulmonary disease, and allergy. The company has a single operating segment: NIOX. The NIOX segment relates to the portfolio of products used to improve asthma diagnosis and management by measuring fractional exhaled nitric oxide (FeNO). Geographically, it derives a majority of its revenue from the Asia Pacific and also has a presence in the European Union, the United States, the United Kingdom, and the Rest of the world.

NIOX Group Headlines

No Headlines